Literature DB >> 24504062

A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia.

Jonathan A Kropski1, Daphne B Mitchell2, Cheryl Markin2, Vasiliy V Polosukhin2, Leena Choi3, Joyce E Johnson4, William E Lawson5, John A Phillips6, Joy D Cogan7, Timothy S Blackwell8, James E Loyd2.   

Abstract

Short telomeres are frequently identified in patients with idiopathic pulmonary fibrosis (IPF) and its inherited form, familial interstitial pneumonia (FIP). We identified a kindred with FIP with short telomeres who did not carry a mutation in known FIP genes TERT or hTR . We performed targeted sequencing of other telomere-related genes to identify the genetic basis of FIP in this kindred. The proband was a 69 year-old man with dyspnea, restrictive pulmonary function test results, and reticular changes on high-resolution CT scan. An older male sibling had died from IPF. The proband had markedly shortened telomeres in peripheral blood and undetectably short telomeres in alveolar epithelial cells. Polymerase chain reaction-based sequencing of NOP10 , TINF2 , NHP2 , and DKC1 revealed that both affected siblings shared a novel A to G 1213 transition in DKC1 near the hTR binding domain that is predicted to encode a Thr405Ala amino acid substitution. hTR levels were decreased out of proportion to DKC1 expression in the T405A DKC1 proband, suggesting this mutation destabilizes hTR and impairs telomerase function. This DKC1 variant represents the third telomere-related gene identified as a genetic cause of FIP. Further investigation into the mechanism by which dyskerin contributes to the development of lung fibrosis is warranted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24504062      PMCID: PMC4077414          DOI: 10.1378/chest.13-2224

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  31 in total

Review 1.  The genetics of dyskeratosis congenita.

Authors:  Philip J Mason; Monica Bessler
Journal:  Cancer Genet       Date:  2011-12

Review 2.  Dyskerin, telomerase and the DNA damage response.

Authors:  BaiWei Gu; Monica Bessler; Philip J Mason
Journal:  Cell Cycle       Date:  2009-01-24       Impact factor: 4.534

3.  A new human dyskerin isoform with cytoplasmic localization.

Authors:  Alberto Angrisani; Mimmo Turano; Lorella Paparo; Concetta Di Mauro; Maria Furia
Journal:  Biochim Biophys Acta       Date:  2011-07-23

4.  Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.

Authors:  Blanche P Alter; Philip S Rosenberg; Neelam Giri; Gabriela M Baerlocher; Peter M Lansdorp; Sharon A Savage
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

5.  Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis.

Authors:  Cecilia García-Sancho; Ivette Buendía-Roldán; Ma Rosario Fernández-Plata; Carmen Navarro; Rogelio Pérez-Padilla; Mario H Vargas; James E Loyd; Moisés Selman
Journal:  Respir Med       Date:  2011-09-13       Impact factor: 3.415

6.  Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort.

Authors:  Coline H M van Moorsel; Matthijs F M van Oosterhout; Nicole P Barlo; Pim A de Jong; Joanne J van der Vis; Henk J T Ruven; H Wouter van Es; Jules M M van den Bosch; Jan C Grutters
Journal:  Am J Respir Crit Care Med       Date:  2010-07-23       Impact factor: 21.405

7.  Transcripts from a novel BMPR2 termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension.

Authors:  R Hamid; L K Hedges; E Austin; J A Phillips; J E Loyd; J D Cogan
Journal:  Clin Genet       Date:  2010-01-20       Impact factor: 4.438

8.  Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.

Authors:  Yongyu Wang; Phillip J Kuan; Chao Xing; Jennifer T Cronkhite; Fernando Torres; Randall L Rosenblatt; J Michael DiMaio; Lisa N Kinch; Nick V Grishin; Christine Kim Garcia
Journal:  Am J Hum Genet       Date:  2008-12-18       Impact factor: 11.025

9.  Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.

Authors:  Erin M Parry; Jonathan K Alder; Stella S Lee; John A Phillips; James E Loyd; Priya Duggal; Mary Armanios
Journal:  J Med Genet       Date:  2011-03-17       Impact factor: 6.318

10.  Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations.

Authors:  Tom J Vulliamy; Michael J Kirwan; Richard Beswick; Upal Hossain; Charlotte Baqai; Anna Ratcliffe; Judith Marsh; Amanda Walne; Inderjeet Dokal
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

View more
  55 in total

Review 1.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

Review 2.  Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.

Authors:  Shruthi Hamsanathan; Jonathan K Alder; Jacobo Sellares; Mauricio Rojas; Aditi U Gurkar; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

3.  Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.

Authors:  Valeriya Gaysinskaya; Susan E Stanley; Soheir Adam; Mary Armanios
Journal:  Chest       Date:  2020-07-22       Impact factor: 9.410

4.  The genetic basis of idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; Timothy S Blackwell; James E Loyd
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

5.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Authors:  Ana L Mora; Mauricio Rojas; Annie Pardo; Moises Selman
Journal:  Nat Rev Drug Discov       Date:  2017-10-30       Impact factor: 84.694

Review 6.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

7.  Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.

Authors:  Chad A Newton; David Zhang; Justin M Oldham; Julia Kozlitina; Shwu-Fan Ma; Fernando J Martinez; Ganesh Raghu; Imre Noth; Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2019-08-01       Impact factor: 21.405

Review 8.  Telomeres in Interstitial Lung Disease: The Short and the Long of It.

Authors:  Andrew M Courtwright; Souheil El-Chemaly
Journal:  Ann Am Thorac Soc       Date:  2019-02

9.  Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families.

Authors:  Jonathan A Kropski; Sara Reiss; Cheryl Markin; Kevin K Brown; David A Schwartz; Marvin I Schwarz; James E Loyd; John A Phillips; Timothy S Blackwell; Joy D Cogan
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

10.  Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis.

Authors:  Jonathan A Kropski; Lisa R Young; Joy D Cogan; Daphne B Mitchell; Lisa H Lancaster; John A Worrell; Cheryl Markin; Na Liu; Wendi R Mason; Tasha E Fingerlin; David A Schwartz; William E Lawson; Timothy S Blackwell; John A Phillips; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.